Citation: Bb. Scott et Cg. Chapman, THE PUTATIVE 116 KDA OSTEOCLAST SPECIFIC VACUOLAR PROTON PUMP SUBUNITHAS UBIQUITOUS TISSUE DISTRIBUTION, European journal of pharmacology, 346(1), 1998, pp. 3-4
Authors:
WILSON S
CHAMBERS JK
PARK JE
LADURNER A
CRONK DW
CHAPMAN CG
KALLENDER H
BROWNE MJ
MURPHY GJ
YOUNG PW
Citation: S. Wilson et al., AGONIST POTENCY AT THE CLONED HUMAN BETA-3 ADRENOCEPTOR DEPENDS ON RECEPTOR EXPRESSION LEVEL AND NATURE OF ASSAY, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 214-221
Authors:
CHAPMAN CG
CLINKENBEARD HE
PARKER KE
SPACKMAN VM
DOBBELAERE DAE
ROBINSON JH
BROWNE MJ
Citation: Cg. Chapman et al., STRUCTURE FUNCTION ANALYSIS OF INTERLEUKIN-4 - INTERSPECIES COMPARISON AND SITE-DIRECTED MUTAGENESIS/, Biochemical Society transactions, 22(2), 1994, pp. 190000234-190000234
Authors:
DODD I
BROWNE MJ
CHAPMAN CG
CRONK D
HASTWELL C
WILSON S
ROBINSON JH
Citation: I. Dodd et al., DELETION OF RESIDUES K296-G302 FROM THE SLOWLY-CLEARED TISSUE-TYPE PLASMINOGEN-ACTIVATOR T-PA DEL (G) LEADS TO PARTIAL LOSS OF PLASMINOGEN ACTIVATING ACTIVITY, Biologicals, 21(3), 1993, pp. 269-274
Authors:
BROWNE MJ
CAREY JE
CHAPMAN CG
DODD I
ESMAIL AF
LAWRENCE GMP
MCMURDO L
WILLIAMSON I
WILSON S
ROBINSON JH
Citation: Mj. Browne et al., PROTEIN ENGINEERING AND COMPARATIVE PHARMACOKINETIC ANALYSIS OF A FAMILY OF NOVEL RECOMBINANT HYBRID AND MUTANT PLASMINOGEN ACTIVATORS, Fibrinolysis, 7(6), 1993, pp. 357-364